Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Researchers discover potential skin cancer prevention target


Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.

The protein, called STAT3, had been known to be involved in cancer, but John DiGiovanni Ph.D., and his colleagues showed that activated STAT3 is necessary for skin cancer to begin and that without it, skin cancer can’t develop. The study, which appears in the September 1, 2004, issue of the Journal of Clinical Investigation, is the first to show STAT3’s critical role in the development of skin cancer. "This study shows STAT3 plays a role in the very earliest steps of the carcinogenic process," says DiGiovanni, the study’s principal investigator and director of M. D. Anderson’s Department of Carcinogenesis which is located in Smithville, about 250 miles from the Houston cancer center. "This is a bona fide target for prevention." It is possible that one day a STAT3 inhibitor could be applied as a topical cream to treat sunburns or precancerous lesions to prevent progression to cancer, he says.

Signal transducers and activators of transcription 3 (STAT3) belong to a class of proteins called transcription factors that can lead to cancer by allowing a healthy cell to respond inappropriately to external signals to divide. Transcription factors are potent proteins because they set off a cascade of events by activating numerous genes, which in turn lead to the production of growth-promoting proteins. Activated STATs have been observed in a wide variety of human cancers, including lymphomas and solid tumors. Because of its newly discovered role in the initiation and promotion stages of skin cancer, intensive effort should now be focused on researching the proteins activated by STAT3, DiGiovanni said.

The researchers became interested in the role of STAT3 when they learned it had been linked to wound healing, a process that shares many of the same features with the process of tumor promotion. Initial studies in DiGiovanni’s lab showed that chemicals known to promote skin cancer also activated STAT3.

To further study the role of STAT3 in skin, the scientists used mice in which STAT3 was missing in skin cells. These mice did not get skin cancer after treatment with a known cancer-causing agent, while mice with normal levels of STAT3 developed numerous skin tumors. Without STAT3, most of the damaged skin cells simply died, while those that survived could undergo proliferation which is necessary for the earliest stages of cancer development.

To further explore the importance of STAT3 in skin cancer, the scientists injected a small piece of DNA called an oligonucleotide, into skin tumors of normal mice. The oligonucleotide was designed to bind STAT3 and prevent it from activating genes. In this experiment, half of the skin tumors injected shrank by more than 60 percent. "We discovered that STAT3 is a unique molecule that regulates critical sets of genes involved in the initiation and promotion of cancer," says DiGiovanni. "Furthermore, we have evidence that if you block the action of STAT3, you get tumors that regress. This makes STAT3 an attractive target for both treatment and prevention of skin cancer."

DiGiovanni’s collaborators included graduate student Keith Chan, Shigetoshi Sano, M.D., and Kaoru Kiguchi , M.D., of M. D. Anderson; Joanne Anders, National Cancer Institute, Bethesda, Md.; and Nobuyasu Komazawa, M.D. and Junji Takeda, M.D.; Osaka University Graduate School of Medicine, Osaka, Japan.

Julie A. Penne | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich

nachricht Researchers Discover New Anti-Cancer Protein
22.03.2018 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>